Screener
Asset Entities ASST Medical Device — Total Assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Asset Entities in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Asset Entities’s 10-Q, filed August 10, 2026.
- Filed
- Aug 10, 2026, 7:01 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054985
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Intangible assets, net | 14,982 | 355 |
| Right-of-use lease assets | 3,825 | 4,037 |
| Other non-current assets | 296 | 95 |
| Total assets | $1,377,109 | $745,527 |
| Liabilities: | ||
| Current liabilities: | ||
| Compensation and benefits payable | $9,624 | $164 |
| Accounts payable and other liabilities | 7,146 | 8,560 |
Item 1. Consolidated Financial Statements
FAQ
- What is Asset Entities's medical device — total assets?
- Asset Entities (ASST) reported medical device — total assets of $18.2M in Q2 2026.
- What does medical device — total assets mean?
- This metric quantifies the total value of resources, including inventory, equipment, and intellectual property, currently allocated to the medical device business segment. It reflects the capital intensity of the segment and the scale of operations dedicated to its specific product lines. Monitoring this figure helps stakeholders assess the company's asset deployment strategy and the potential for future revenue generation within this specific vertical.
Ask your AI about Asset Entities's medical device — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude